Monthly Archives: January 2023

//January

Joint letter calls for workforce plan to include whole of pharmacy

PSNC and other pharmacy leaders have warned the Government about a lack of engagement with stakeholders around the development of its long-term workforce plan. A joint letter signed by representatives from 14 pharmacy organisations has called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across [...]

The post Joint letter calls for workforce plan to include whole of pharmacy appeared first on PSNC Website.

By |January 11th, 2023|Lexpos News|Comments Off on Joint letter calls for workforce plan to include whole of pharmacy

Free PPE for pharmacy teams extended until March 2024

The Government’s scheme providing free personal protective equipment (PPE) to health and care providers, including community pharmacies in England, has been extended for another year. The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social care staff [...]

The post Free PPE for pharmacy teams extended until March 2024 appeared first on PSNC Website.

By |January 10th, 2023|Lexpos News|Comments Off on Free PPE for pharmacy teams extended until March 2024

PQS: Declaration questions published

The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2022/23 Pharmacy Quality Scheme (PQS) declaration so community pharmacy contractors can view these ahead of making their declaration. The questions are available on the NHSBSA PQS hub page; contractors should scroll down to the ‘Declaration questions’ section where they can [...]

The post PQS: Declaration questions published appeared first on PSNC Website.

By |January 9th, 2023|Lexpos News|Comments Off on PQS: Declaration questions published

Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens – Updated

Update 25th May 2023: Norditropin® Flexpro® 5mg will be out of stock from early August until at least September 2023. Norditropin® Flexpro® 10mg pens will be out of stock from mid-July until at least September 2023. Norditropin® Flexpro® 15mg pens will be out of stock from mid-June until at least September 2023. Other alternative somatropin [...]

The post Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens – Updated appeared first on PSNC Website.

By |January 3rd, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens – Updated

MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)

Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) Drug alert number: EL (23)A/01 Date issued: 3 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bylvay 1200 micrograms Hard Capsules, PLGB 36216/0004 Batch number Expiry date Pack size First distributed [...]

The post MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) appeared first on PSNC Website.

By |January 3rd, 2023|class 4, defect, Lexpos News, mhra|Comments Off on MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)